PRECLINICAL CHARACTERISATION OF MIV-8... - HFI Connect - Hep...

HFI Connect - Hepatitis

960 members1,215 posts

PRECLINICAL CHARACTERISATION OF MIV-802, A NOVEL URIDINE NUCLEOTIDE HCV NS5B POLYMERASE INHIBITOR, FOR TREATMENT OF HEPATITIS C VIRUS INFECT

kcohen profile image
0 Replies

natap.org/2015/EASL/EASL_15...

Written by
kcohen profile image
kcohen
To view profiles and participate in discussions please or .